A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma
CONCLUSION: A systematic analysis of NRGs can help identify potential necroptosis-related mechanisms and provide novel biomarkers for MM prognosis prediction, tumor microenvironment evaluation, and personalized treatment planning.PMID:38361483 | DOI:10.1177/15330338241232554
Source: Technology in Cancer Research and Treatment - Category: Cancer & Oncology Authors: Jun-Yao Jiang Fang-Yi Yao Jing Liu Xin-Lu Wang Bo Huang Fang-Min Zhong Xiao-Zhong Wang Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Genetics | Myeloma | Revlimid | Study | Velcade